OSBORNE DAVID W
SEC CIK 1252999 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | Chief Technical Off | 268.9K | — | $171.4K | 8 | 2022-03-01 | 2023-03-06 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
OSBORNE DAVID W made no open-market trades at ARQT in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | 2023-03-06 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $15.26 | -690 | 268.9K | -0.3% | -$10.5K | |
| D | 2023-03-06 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | A - Grant | $0.00 | +14.9K | 269.5K | +6% | $0 |
| M | 2023-03-02 | 2023-02-28+ | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $15.96 | -2,005 | 254.6K | -0.8% | -$32.0K |
| 2022-07-12 | 2022-07-08 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $25.41 | -2,197 | 256.6K | -0.8% | -$55.8K | |
| 2022-04-21 | 2022-04-21 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $20.42 | -2,197 | 257.2K | -0.8% | -$44.9K | |
| D | 2022-03-07 | 2022-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | A - Grant | $0.00 | +13.3K | 260.3K | +5% | $0 |
| DM | 2022-03-07 | 2022-03-04+ | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $16.85 | -856 | 259.5K | -0.3% | -$14.4K |
| 2022-03-03 | 2022-03-01 | ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Off | S - Sale | $17.75 | -775 | 247.0K | -0.3% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations